| Issue Date |
Title |
Author(s) |
| 2018 |
Aflibercept plus FOLFIRI in Asian patients with pretreated metastatic colorectal cancer: a randomized Phase III study |
Li, Jin;Xu, Ruihua;Qin, Shukui;Liu, Tianshu;Pan, Hongming;Xu, Jianming;Bi, Feng;Lim, Robert;Zhang, Suzhan;Ba, Yi;Bai, Yuxian;Fan, Nanfeng;Tsuji, Akihito;Yeh, Kun-Huei;Ma, Brigette;Wei, Vivian;Shi, Dongmei;Magherini, Emmanuelle;Shen, Lin |
| 2019 |
Association between hand-foot skin reaction (HFSR) and survival benefit of fruquintinib in FRESCO trial. |
Li, Jin;Qin, Shukui;Bai, Yuxian;Deng, Yanhong;Yang, Lei;Xu, Ruihua;Chen, Zhendong;Zhong, Haijun;Pan, Hongming;Guo, Weijian;Shu, Yongqian;Yuan, Ying;Xu, Jianming;Shen, Lin;Wang, Ning;Zhu, Chao;Fan, Songhua;Gong, Wei;Wang, Wei |
| 2019 |
Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018) |
Xu, Jianmin;Fan, Jia;Qin, Xinyu;Cai, Jianqiang;Gu, Jin;Wang, Shan;Wang, Xishan;Zhang, Suzhan;Zhang, Zhongtao;Ba, Yi;Bu, Jianhong;Cai, Jianhui;Cai, Sanjun;Zeng, Shan;Zeng, Zhaochong;Chen, Gong;Chen, Yu;Chen, Zihua;Chen, Zongyou;Cheng, Jiemin;Chi, Pan;Dai, Guanghai;Dai, Yong;Deng, Yanhong;Ding, Kefeng;Fang, Xuedong;Fu, Chuangang;Gong, Jianping;Hao, Chunyi;He, Yulong;Huang, Zhongcheng;Ji, Jiafu;Jia, Baoqing;Jiang, Kewei;Jin, Jing;Kong, Dalu;Lan, Ping;Li, Dechuan;Li, Guoli;Li, Jin;Li, Leping;Li, Yunfeng;Li, Zhixia;Liang, Houjie;Liang, Xiaobo;Lin, Feng;Lin, Jianjiang;Liu, Hongjun;Liu, Tianshu;Liu, Yunpeng;Pan, Hongming;Pan, Zhizhong;Pei, Haiping;Peng, Tao;Ren, Li;Shen, Lin;Song, Chun;Song, Tianqiang;Su, Xiangqian;Sun, Yihong;Tao, Min;Tian, Liguo;Wan, Desen;Wang, Jianping;Wang, Guiying;Wang, Guiyu;Wang, Haijiang;Wang, Jianhua;Wang, Lei;Wang, Xin;Wang, Yajie;Wang, Yi;Wang, Ziqiang;Wei, Ye;Wei, Dong;Xia, Feng;Xia, Jianguo;Xia, Lijian;Xing, Baocai;Xiong, Bin;Xu, Jianming;Xu, Nong;Xu, Ruihua;Xu, Ye;Xu, Zekuan;Xu, Zhongfa;Yang, Shujun;Yao, Hongwei;Ye, Yingjiang;Yu, Peiwu;Yuan, Ying;Zhang, Jun;Zhang, Keliang;Zhang, Wei;Zhang, Xiaotian;Zhang, Yanqiao;Zhang, Youcheng;Zhang, Zhen;Zhao, Qingchuan;Zhao, Ren;Zheng, Shu;Zhou, Aiping;Zhou, Jian;Zhou, Zongguang |
| 2019 |
Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 |
Zhang, Suzhan;Li, Jin;Cai, Sanjun;Xu, Ruihua;Zhang, Zhen;Yuan, Ying;Chen, Gong;Wang, Xicheng;Cai, Muyan;Cai, Sanjun;Chen, Gong;Gao, Yuanhong;Lai, Maode;Li, Jin;Li, Guichao;Li, Xinxiang;Liang, Houjie;Nan, Kejun;Ren, Li;Sheng, Weiqi;Wang, Yi;Wang, Xicheng;Xu, Jianmin;Xu, Ruihua;Yuan, Ying;Zhang, Suzhan;Zhang, Zhen;Zhou, Aiping |
| 18-Feb-2020 |
Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China |
Xu, Ruihua;Wang, Wei;Zhu, Bo;Lin, Xiaoyan;Ma, Dong;Zhu, Lingjun;Zhao, Qingchuan;Nie, Yongzhan;Cai, Xiaohong;Li, Qi;Fang, Weijia;Li, Hongyan;Wang, Ning;Chen, Yun;Peng, Cike;Fang, Honghao;Shen, Lin |
| Oct-2021 |
Efficacy and safety of a novel anti-HER2 therapeutic antibody RC48 in patients with HER2-overexpressing, locally advanced or metastatic gastric or gastroesophageal junction cancer: a single-arm phase II study |
Peng, Zhi;Liu, Tianshu;Wei, Jia;Wang, Airong;He, Yifu;Yang, Liuzhong;Zhang, Xizhi;Fan, Nanfeng;Luo, Suxia;Li, Zhen;Gu, Kangsheng;Lu, Jianwei;Xu, Jianming;Fan, Qingxia;Xu, Ruihua;Zhang, Liangming;Li, Enxiao;Sun, Yuping;Yu, Guohua;Bai, Chunmei;Liu, Yong;Zeng, Jiangzheng;Ying, Jieer;Liang, Xinjun;Xu, Nong;Gao, Chao;Shu, Yongqian;Ma, Dong;Dai, Guanghai;Li, Shengmian;Deng, Ting;Cui, Yuehong;Fang, Jianmin;Ba, Yi;Shen, Lin |
| 2017 |
Efficacy and safety of weekly nab-paclitaxel plus gemcitabine in Chinese patients with metastatic adenocarcinoma of the pancreas: a phase II study |
Xu, Ruihua;Yu, Xianjun;Hao, Jihui;Wang, Liwei;Pan, Hongming;Han, Guohong;Xu, Jianming;Zhang, Yanqiao;Yang, Shujun;Chen, Jia;Ying, Jieer;Dai, Guanghai;Li, Mingyu;Begic, Damir;Lu, Brian;Shen, Lin |
| 2016 |
Efficacy of trastuzumab beyond progression in HER2 positive advanced gastric cancer: a multicenter prospective observational cohort study |
Li, Qian;Jiang, Huiqin;Li, Hong;Xu, Ruihua;Shen, Lin;Yu, Yiyi;Wang, Yan;Cui, Yuehong;Li, Wei;Yu, Shan;Liu, Tianshu |
| 2019 |
Expert consensus on multidisciplinary therapy of colorectal cancer with lung metastases (2019 edition) |
Li, Jian;Yuan, Ying;Yang, Fan;Wang, Yi;Zhu, Xu;Wang, Zhenghang;Zheng, Shu;Wan, Desen;He, Jie;Wang, Jianping;Ba, Yi;Bai, Chunmei;Bai, Li;Bai, Wei;Bi, Feng;Cai, Kaican;Cai, Muyan;Cai, Sanjun;Chen, Gong;Chen, Keneng;Chen, Lin;Chen, Pengju;Chi, Pan;Dai, Guanghai;Deng, Yanhong;Ding, Kefeng;Fan, Qingxia;Fang, Weijia;Fang, Xuedong;Feng, Fengyi;Fu, Chuangang;Fu, Qihan;Gu, Yanhong;He, Yulong;Jia, Baoqing;Jiang, Kewei;Lai, Maode;Lan, Ping;Li, Enxiao;Li, Dechuan;Li, Jin;Li, Leping;Li, Ming;Li, Shaolei;Li, Yexiong;Li, Yongheng;Li, Zhongwu;Liang, Xiaobo;Liang, Zhiyong;Lin, Feng;Lin, Guole;Liu, Hongjun;Liu, Jianzhong;Liu, Tianshu;Liu, Yunpeng;Pan, Hongming;Pan, Zhizhong;Pei, Haiping;Qiu, Meng;Qu, Xiujuan;Ren, Li;Shen, Zhanlong;Sheng, Weiqi;Song, Chun;Song, Lijie;Sun, Jianguo;Sun, Lingyu;Sun, Yingshi;Tang, Yuan;Tao, Min;Wang, Chang;Wang, Haijiang;Wang, Jun;Wang, Shubin;Wang, Xicheng;Wang, Xishan;Wang, Ziqiang;Wu, Aiwen;Wu, Nan;Xia, Lijian;Xiao, Yi;Xing, Baocai;Xiong, Bin;Xu, Jianmin;Xu, Jianming;Xu, Nong;Xu, Ruihua;Xu, Zhongfa;Yang, Yue;Yao, Hongwei;Ye, Yingjiang;Yu, Yonghua;Yu, Yueming;Yue, Jinbo;Zhang, Jingdong;Zhang, Jun;Zhang, Suzhan;Zhang, Wei;Zhang, Yanqiao;Zhang, Zhen;Zhang, Zhongtao;Zhao, Lin;Zhao, Ren;Zhou, Fuxiang;Zhou, Jian;Jin, Jing;Gu, Jin;Shen, Lin |
| Jul-2021 |
First-Line (1L) nivolumab (NIVO) plus chemotherapy (chemo) versus chemo in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): CheckMate 649 Chinese subgroup analysis. |
Shen, Lin;Bai, Yuxian;Lin, Xiaoyan;Li, Wei;Wang, Jufeng;Zhang, Xiaochun;Pan, Hongming;Bai, Chunmei;Bai, Li;Cheng, Ying;Zhang, Jingdong;Zhong, Haijun;Ba, Yi;Hu, Wenwei;Xu, Ruihua;Guo, Weijian;Qin, Shukui;Yang, Nong;Lu, Jianwei;Shitara, Kohei;Lei, Ming;Li, Mingshun;Bao, Nicole;Chen, Tian;Liu, Tianshu |
| Oct-2022 |
First-line nivolumab plus chemotherapy vs chemotherapy in patients with advanced gastric, gastroesophageal junction and esophageal adenocarcinoma: CheckMate 649 Chinese subgroup analysis |
Liu, Tianshu;Bai, Yuxian;Lin, Xiaoyan;Li, Wei;Wang, Jufeng;Zhang, Xiaochun;Pan, Hongming;Bai, Chunmei;Bai, Li;Cheng, Ying;Zhang, Jingdong;Zhong, Haijun;Ba, Yi;Hu, Wenwei;Xu, Ruihua;Guo, Weijian;Qin, Shukui;Yang, Nong;Lu, Jianwei;Shitara, Kohei;Lei, Ming;Li, Mingshun;Bao, Nicole;Chen, Tian;Shen, Lin |
| 2013 |
Genotyping of IL-8-251 T > A yields prognostic information in patients with gastric carcinoma |
Cai, Xiuyu;Hu, Weihan;Zhang, Bei;Dai, Ni;Xu, Ruihua;Qiu, Huijuan;Wang, Deshen;Li, Zhiming;Jiang, Wenqi |
| 15-Jan-2021 |
Identification of "regulation of RhoA activity panel" as a prognostic and predictive biomarker for gastric cancer |
Huang, Wenwen;Zhao, Songhui;Zhang, Cheng;Li, Zhongwu;Ge, Sai;Lian, Baofeng;Feng, Hui;Wang, Kai;Xu, Ruihua;Ji, Jiafu;Gao, Jing;Shi, Weiwei;Shen, Lin |
| 2014 |
The Multicenter, Phase II Prospective Study of Paclitaxel Plus Capecitabine as First-Line Chemotherapy in Advanced Gastric Carcinoma |
Gong, Jifang;Hu, Bing;Zhang, Xiaotian;Zhang, Fengchun;Zhang, Jun;Xu, Nong e;Fan, Qingxia;Bai, Yuxian;Jiao, Shunchang;Wang, Jinwan;Bai, Chunmei;Zheng, Leizhen;Shi, Yingqiang;Liu, Yunpeng;Liang, Jun;Hu, Guoqing;Cheng, Ying;Xu, Ruihua;Bai, Yu;Shen, Lin |
| Jul-2020 |
Multiparametric MRI and Whole Slide Image-Based Pretreatment Prediction of Pathological Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer: A Multicenter Radiopathomic Study |
Shao, Lizhi;Liu, Zhenyu;Feng, Lili;Lou, Xiaoying;Li, Zhenhui;Zhang, Xiao-Yan;Wan, Xiangbo;Zhou, Xuezhi;Sun, Kai;Zhang, Da-Fu;Wu, Lin;Yang, Guanyu;Sun, Ying-Shi;Xu, Ruihua;Fan, Xinjuan;Tian, Jie |
| Aug-2020 |
National guidelines for diagnosis and treatment of colorectal cancer 2020 in China (English version) |
Sun, Yan;Zheng, Shu;Wan, Desen;Gu, Jin;Wang, Jianping;Zhang, Suzhan;Cai, Sanjun;Fang, Xuedong;Fu, Chuangang;Jia, Baoqing;Kong, Dalu;Lan, Ping;Pan, Zhizhong;Pei, Haiping;Qiu, Huizhong;Song, Chun;Wang, Guiying;Wang, Xishan;Wang, Ziqiang;Xu, Jianmin;Xu, Zhongfa;Yan, Jin;Ye, Yingjiang;Yu, Yueming;Zhang, Zhongtao;Zhao, Ren;Lian, Lei;Liu, Qian;Peng, Yifan;Shen, Lin;Xu, Ruihua;Li, Jin;Ba, Yi;Bai, Chunmei;Bai, Li;Deng, Yanhong;Li, Jian;Liu, Tianshu;Liu, Yunpeng;Pan, Hongming;Tao, Min;Xu, Jianming;Yuan, Xianglin;Yuan, Ying;Zhang, Yanqiao;Zhou, Aiping;Wang, Feng;Wang, Xicheng;Li, Yexiong;Zhang, Zhen;Cai, Yong;Gao, Yuanhong;Jin, Jing;Li, Yongheng;Liu, Shixin;Wang, Renben;Wu, Junxin;Zhang, Hongyan;Zhu, Li;Zhu, Yuan;Tang, Yuan;Liang, Zhiyong;Jin, Mulan;Liang, Li;Qiu, Zhiqiang;Sheng, Weiqi;Sun, Baocun;Xue, Weicheng;Zhou, Weixun;Sun, Yingshi;Dong, Jiangning;Wang, Yi;Yu, Tao;Zhang, Xiaoyan;Zhou, Zhiyang;Sun, Ruijia;Wang, Juan;Sun, Ruijia;Tang, Yuan;Wang, Feng;Wang, Juan;Zhou, Weixun;Yang, Yong;Chen, Jiajia;Chen, Yongkang;Cheng, Yu;Han, Zihan;Huang, An;Huang, Dandan;Li, Xin;Li, Yukun;Shi, Jingyi;Shi, Mengyuan;Song, Can;Wang, Hanyang;Xu, Jingxuan |
| 2019 |
Pertuzumab in combination with trastuzumab and chemotherapy for Chinese patients with HER2-positive metastatic gastric or gastroesophageal junction cancer: a subpopulation analysis of the JACOB trial |
Liu, Tianshu;Qin, Yanru;Li, Jin;Xu, Ruihua;Xu, Jianming;Yang, Shujun;Qin, Shukui;Bai, Yuxian;Wu, Changping;Mao, Yixiang;Wu, Haiyan;Ge, Yilin;Shen, Lin |
| 2018 |
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. |
Li, Jin;Xu, Ruihua;Bai, Yuxian;Xu, Jianming;Liu, Tianshu;Shen, Lin;Wang, Liwei;Pan, Hongming;Han, Rubing;Chen, Yun;Peng, Cike;Fan, Songhua;Hua, Ye |
| 2018 |
Quality-adjusted time without symptoms or toxicity (Q-TWiST) of patients with metastatic colorectal cancer (mCRC) treated with fruquintinib in a phase II clinical trial. |
Li, Jin;Xu, Ruihua;Bai, Yuxian;Xu, Jianming;Liu, Tianshu;Shen, Lin;Wang, Liwei;Pan, Hongming;Han, Rubing;Chen, Yun;Peng, Cike;Fan, Songhua;Hua, Ye |
| Aug-2020 |
Radiopathomics strategy combining multiparametric MRI with whole-slide image for pretreatment prediction of tumor regression grade to neoadjuvant chemoradiotherapy in rectal cancer |
Shao, Lizhi;Liu, Zhenyu;Feng, Lili;Lou, Xiaoying;Li, Zhenhui;Zhang, Xiao-Yan;Zhou, Xuezhi;Sun, Kai;Zhang, Da-Fu;Wu, Lin;Yang, Guanyu;Sun, Ying-Shi;Xu, Ruihua;Wan, Xiangbo;Fan, Xinjuan;Tian, Jie |
